why choose us

First received: August 06, 2024

Clinical Trial: A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Dry Eye Disease

Study Type: INTERVENTIONAL


Official Title: A Phase 3b Study to Investigate the Effect of 0.003% AR-15512 on the Ocular Surface Characteristics of Subjects With Dry Eye Disease

Brief Summary: The purpose of this study is to evaluate the effect of AR-15512 ophthalmic solution 0.003% (0.003% AR-15512) on ocular surface characteristics of subjects with dry eye disease (DED).

Read more